» Articles » PMID: 33230005

Cage-lid Hanging Behavior As a Translationally Relevant Measure of Pain in Mice

Abstract

The development of new analgesic drugs has been hampered by the inability to translate preclinical findings to humans. This failure is due in part to the weak connection between commonly used pain outcome measures in rodents and the clinical symptoms of chronic pain. Most rodent studies rely on the use of experimenter-evoked measures of pain and assess behavior under ethologically unnatural conditions, which limits the translational potential of preclinical research. Here, we addressed this problem by conducting an unbiased, prospective study of behavioral changes in mice within a natural homecage environment using conventional preclinical pain assays. Unexpectedly, we observed that cage-lid hanging, a species-specific elective behavior, was the only homecage behavior reliably impacted by pain assays. Noxious stimuli reduced hanging behavior in an intensity-dependent manner, and the reduction in hanging could be restored by analgesics. Finally, we developed an automated approach to assess hanging behavior. Collectively, our results indicate that the depression of hanging behavior is a novel, ethologically valid, and translationally relevant pain outcome measure in mice that could facilitate the study of pain and analgesic development.

Citing Articles

Discordance between preclinical and clinical testing of Na V 1.7-selective inhibitors for pain.

Yang J, Xie Y, Smith R, Ratte S, Prescott S Pain. 2025; 166(3):481-501.

PMID: 39928833 PMC: 11808711. DOI: 10.1097/j.pain.0000000000003425.


Effects of Selective and Mixed-Action Kappa and Delta Opioid Receptor Agonists on Pain-Related Behavioral Depression in Mice.

Negus S, M St Onge C, Lee Y, Li M, Rice K, Zhang Y Molecules. 2024; 29(14).

PMID: 39064909 PMC: 11279860. DOI: 10.3390/molecules29143331.


Modulating Neural Circuits of Pain in Preclinical Models: Recent Insights for Future Therapeutics.

Viellard J, Bouali-Benazzouz R, Benazzouz A, Fossat P Cells. 2024; 13(12.

PMID: 38920628 PMC: 11202162. DOI: 10.3390/cells13120997.


Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in Mice.

Santos E, Akbarali H, Bow E, Chambers D, Gutman E, Jacobson A J Pharmacol Exp Ther. 2024; 391(2):138-151.

PMID: 38637015 PMC: 11493441. DOI: 10.1124/jpet.124.002153.


The pain target Na1.7 is expressed late during human iPS cell differentiation into sensory neurons as determined in high-resolution imaging.

Liu Y, Balaji R, Szymanski de Toledo M, Ernst S, Hautvast P, Kesdogan A Pflugers Arch. 2024; 476(6):975-992.

PMID: 38538988 PMC: 11139713. DOI: 10.1007/s00424-024-02945-w.